Target intelligence / Profile preview

Erythrocyte membrane protein band 4.2 (EPB42)

Target
EPB42
Molecular classification
Cytoskeletal protein, Peripheral membrane protein, ATP-binding protein
01

Overview

Erythrocyte membrane protein band 4.2 (EPB42) is a peripheral membrane ATP-binding protein that is one of the most abundant components of the human red blood cell (erythrocyte) membrane[1][4][5]. It plays an essential role in stabilizing erythrocyte membrane structure, primarily by regulating the association between the band 3 protein and ankyrin, and is part of the ankyrin-1 complex[1][4][5]. Through its physical association with band 3, ankyrin, and CD47, protein 4.2 helps maintain the distinctive shape and mechanical properties of erythrocytes[4]. Deficiencies or mutations in EPB42 cause disorders such as hereditary spherocytosis and elliptocytosis, characterized by destabilization of the erythrocyte membrane and hemolytic anemia[1][4][5]. Protein 4.2 is structurally similar to members of the transglutaminase protein family, although it lacks transglutaminase enzymatic activity[2][4]. There is currently no evidence that it is a direct therapeutic target or that any drugs interact with it[1][4][5].

Other names
Protein 4.2EPB42E42PP4.2Erythrocyte protein 4.2PAMGC116735MGC116737Erythrocyte surface protein band 4.2SPH5
02

Biological functions

Regulation of erythrocyte shapeRegulation of erythrocyte mechanical propertiesStructural constituent of cytoskeletonAssociation with band 3 and ankyrin complexATP-binding
03

Disease associations

Hereditary spherocytosisHereditary hemolytic anemiaRecessive spherocytic elliptocytosis

Beyond the preview

Go deeper on Erythrocyte membrane protein band 4.2 (EPB42).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Erythrocyte membrane protein band 4.2 (EPB42).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call